痴呆症护理研究和心理社会因素
1University of Kansas Medical Center, Kansas City, KS, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
肌酸单酸 (CrM) 补充剂对阿尔茨海默病 (AD) 患者是可行的,显示大脑能量代谢和认知功能的显著改善. 进一步研究CRM作为辅助疗法是有必要的.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 大脑代谢,特别是肌酸 (Cr) 系统,在阿尔茨海默病 (AD) 中受到损害.
- 肌酸单酸 (CrM) 在AD小鼠模型中显示出希望,但缺乏人类数据.
- 这项研究调查了CRM在人类AD患者中的可行性和初步效果.
研究的目的:
- 评估阿尔茨海默氏病 (AD) 患者为期八周的肌酸单酸 (CrM) 补充剂的可行性.
- 探索CrM对AD大脑生物能学和认知功能影响的初步证据.
- 建立未来临床试验的基础,对阿尔茨海默病的CrM.
主要方法:
- 这是一项开放式单臂研究,涉及20名可能患有阿尔茨海默病的参与者,他们每天接受20gCrM,持续8周.
- 通过日常合规跟踪评估可行性.
- 测量结果包括血清和大脑总肌酸 (H MRS),淋巴细胞ATP/ADP产生,线粒体呼吸和认知功能 (NIH工具箱).
主要成果:
- 观察到高度的合规性 (95%) 和可行性.
- 血清和大脑总肌酸水平显著增加.
- 淋巴细胞ATP和ADP的产生增加,女性线粒体呼吸显著改善.
- 认知功能在全球流体认知,工作记忆和执行功能中得到改善.
结论:
- 在阿尔茨海默病患者中,八周的高剂量CrM补充是可行的.
- 该干预措施对生物能标志物和认知表现产生了积极影响.
- 初步发现支持进一步调查CrM作为一种潜在的负担得起的AD治疗辅助疗法.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
